GEN Exclusives

More »

GEN News Highlights

Back to Item »

Quark and Nitto Denko to Co-Develop siRNA Therapeutics for Fibrotic Diseases

Partnership will combine Quark’s RNAi technologies with Nitto’s drug delivery and therapeutic concept IP.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?